• Pharmacokinetic Variability of CSBTA in MASH Mouse Models

  2026-07-18

  This study elucidates how metabolic dysfunction-associated steatohepatitis (MASH) fundamentally alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in high-fat, high-cholesterol diet-induced mice. The findings provide mechanistic insight into transporter and enzyme modulation, supporting rational dosing in MASLD/MASH interventions.

• Dacomitinib (PF-00299804): Orchestrating Pan-HER Inhibition

  2026-07-17

  Explore the advanced mechanisms and applications of Dacomitinib (PF-00299804) as a potent pan-HER inhibitor for cancer research. This article offers fresh insight into its role in apoptosis induction and cell cycle arrest, and bridges these findings with emerging ferroptosis strategies in tumor biology.

• Chondrocyte-Targeted NAC Nanoparticles Inhibit Ferroptosis i

  2026-07-17

  This study introduces chondrocyte-targeted PLGA nanoparticles delivering N-acetylcysteine (NAC) that protect cartilage and attenuate osteoarthritis (OA) by inhibiting ferroptosis via glutathione maintenance. The findings demonstrate enhanced joint retention, effective ROS scavenging, and disease-modifying potential, with implications for sustained redox modulation in OA therapy.

• Liproxstatin-1: Potent Ferroptosis Inhibitor for Cell Death

  2026-07-16

  Liproxstatin-1 is a highly potent ferroptosis inhibitor with an IC50 of 22 nM, offering robust protection against iron-dependent cell death and lipid peroxidation. Its specificity and efficacy make it a gold-standard tool in mechanistic ferroptosis research and organ injury models.

• METTL17 Regulates Ferroptosis via Mitochondrial Translation

  2026-07-16

  The referenced study uncovers a critical role for the mitochondrial protein METTL17 in coordinating ferroptosis resistance and tumorigenesis in colorectal cancer by regulating mitochondrial RNA methylation and translation. These findings identify METTL17 as a promising therapeutic target for sensitizing CRC cells to ferroptosis-based treatments, with significant implications for cancer biology and intervention strategies.

• Genetic Manipulation of A40926 Biosynthesis: Pathway Insight

  2026-07-15

  This review dissects the genetic and biosynthetic pathway of A40926, a teicoplanin-family glycopeptide and direct precursor to dalbavancin, focusing on the isolation and manipulation of the dbv gene cluster in Nonomuraea. The study demonstrates how pathway engineering yields novel antibiotic derivatives and reveals biosynthetic distinctions among glycopeptide families, advancing research on combating resistant Gram-positive pathogens.

• Molecular Mechanisms of Paroxetine: Beyond SERT Inhibition

  2026-07-15

  The reference study provides a comprehensive review of paroxetine's molecular pharmacology, highlighting its selective serotonin reuptake inhibitor (SSRI) mechanism, as well as its interactions with cytochrome P450 enzymes and several kinases. These findings expand the therapeutic and experimental relevance of paroxetine, supporting its application in both neuropsychiatric and oncology research.

• 2,2,2-Trichloroethanol: Small Molecule Biochemical for Prote

  2026-07-14

  2,2,2-Trichloroethanol stands out as a high-purity small molecule biochemical reagent, empowering researchers with reproducible, high-sensitivity protein analysis and signal transduction workflows. Its robust solubility and validated performance enable streamlined, reliable molecular biology research, especially in advanced neurobiology applications.

• Afatinib (BIBW 2992): Applied Workflows in Cancer Assembloid

  2026-07-14

  Afatinib’s irreversible inhibition of EGFR, HER2, and HER4 empowers advanced patient-derived assembloid models to capture complex drug responses and resistance. This guide translates cutting-edge research into practical protocols, troubleshooting, and actionable insights for cancer biology and targeted therapy research.

• CDC42 Polarity Regulates Intestinal Stem Cell Fate via YAP-m

  2026-07-13

  Zhang et al. uncovered that CDC42-driven apical-basal polarity is essential for the balance between intestinal stem cells (ISCs) and transit amplifying (TA) cells, acting through a YAP-EGF-mTOR signaling axis independently of canonical Wnt pathways. This mechanistic insight reframes epithelial polarity as a decisive regulator of intestinal crypt homeostasis and offers new directions for gastrointestinal stem cell research.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-13

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of resolving proteins and peptides in the 1–10 kDa range, which are not efficiently separated by standard Tris-glycine SDS-PAGE systems. It is intended for research workflows requiring high-resolution analysis of small proteins and peptides and should not be used for diagnostic or clinical applications.

• Enhancing Gram-Negative Assays: Aztreonam (SKU A5931) in Foc

  2026-07-12

  This article provides an evidence-driven exploration of Aztreonam (SKU A5931) for researchers facing challenges in Gram-negative bacterial assays. Drawing on recent resistance surveillance and hands-on laboratory scenarios, it demonstrates how Aztreonam’s defined solubility, reproducibility, and metabolic insights optimize experimental reliability for biomedical scientists.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Rese

  2026-07-10

  This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, more faithfully recapitulating the tumor microenvironment than traditional organoid cultures. The approach enhances the physiological relevance of preclinical drug sensitivity testing, providing new insights into resistance mechanisms and personalized therapy optimization.

• Morphological Profiling Reveals HSPB7 Rescue in Titin Cardio

  2026-07-09

  This study introduces CARDIO, a high-content morphological profiling assay, to systematically investigate cardiomyocyte responses in genetic models of dilated cardiomyopathy. The work uncovers HSPB7 loss as a novel modulator capable of rescuing contractile function in titin-deficient heart cells, offering new insight for heart failure research.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-07-09

  This study introduces a novel patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, closely mimicking the complexity of primary tumors. The approach enhances the physiological relevance of preclinical drug testing and offers new insights into mechanisms of drug resistance and personalized therapy strategies.

7666 records 5/512 page Previous Next 12345 下5页 Last page